You are here

  • Home
  • Archive
  • Volume 59, Issue 9
  • Catastrophic chemotherapy toxicity leading to diagnosis of Fanconi anaemia due to FANCD1/BRCA2 during adulthood: description of an emerging phenotype

Article info

Article menu
Download PDFPDF
Cancer genetics
Short report
Catastrophic chemotherapy toxicity leading to diagnosis of Fanconi anaemia due to FANCD1/BRCA2 during adulthood: description of an emerging phenotype

Authors

  • Emilia Ip Cancer Genetics, Liverpool Hospital, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Catriona McNeil Medical Oncology, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia Department of Medicine, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Peter Grimison Medical Oncology, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Tahlia Scheinberg Medical Oncology, Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia Department of Medicine, The University of Sydney, Sydney, New South Wales, Australia Clinical Prostate Cancer Group, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Emma Tudini Department of Genetics and Computational Biology, Queensland Institute of Medical Research, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • Gladys Ho Western Sydney Genetics Program, Children's Hospital at Westmead, Westmead, New South Wales, Australia Discipline of Paediatrics and Child Health, University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Rodney J Scott Division of Molecular Medicine, NSW Health Pathology, Newcastle, New South Wales, Australia School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, New South Wales, Australia Hunter Medical Research Institute, New Lambton, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Christina Brown Haematology Unit, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Charbel Sandroussi Department of Hepatobiliary and Upper Gastrointestinal Surgery, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Pascale Guitera Department of Medicine, The University of Sydney, Sydney, New South Wales, Australia Melanoma Institute Australia, North Sydney, New South Wales, Australia Dermatology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Amanda B Spurdle Department of Genetics and Computational Biology, Queensland Institute of Medical Research, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • Annabel Goodwin Cancer Genetics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia Medical Oncology, Concord Repatriation General Hospital, Concord, New South Wales, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Annabel Goodwin, Cancer Genetics, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia; annabel.goodwin{at}health.nsw.gov.au
View Full Text

Citation

Ip E, McNeil C, Grimison P, et al
Catastrophic chemotherapy toxicity leading to diagnosis of Fanconi anaemia due to FANCD1/BRCA2 during adulthood: description of an emerging phenotype
Journal of Medical Genetics 2022;59:912-915.

Publication history

  • Received July 1, 2021
  • Accepted September 7, 2021
  • First published October 25, 2021.
Online issue publication 
November 15, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.